These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3022094)

  • 21. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat.
    Lumpkin MD; Samson WK; McCann SM
    Endocrinology; 1983 May; 112(5):1711-7. PubMed ID: 6403333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Permissive, mediating and potentiating effects of vasopressin in the ACTH and beta-endorphin response to histamine and restraint stress.
    Kjaer A; Knigge U; Bach FW; Warberg J
    Neuroendocrinology; 1993 Nov; 58(5):588-96. PubMed ID: 8115028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desensitization of renal vasopressin-stimulated adenylate cyclase by a vasopressor and antidiuretic antagonist, [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl)-D-tyrosine, 4-valine]arginine vasopressin.
    Chang P; Kimura K
    Biochem Biophys Res Commun; 1987 Apr; 144(2):770-8. PubMed ID: 3579941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acute ether or restraint stress on plasma corticotropin-releasing hormone, vasopressin and oxytocin levels in the rat.
    Hashimoto K; Murakami K; Takao T; Makino S; Sugawara M; Ota Z
    Acta Med Okayama; 1989 Jun; 43(3):161-7. PubMed ID: 2548372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
    Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of corticotropin-releasing factor, arginine vasopressin and oxytocin on the polymorphism of plasma adrenocorticotropic hormone in the rat fetus in late pregnancy.
    Deloof S; Chatelain A; Leprêtre A
    Biol Neonate; 1994; 65(5):331-9. PubMed ID: 8054402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histamine- and stress-induced secretion of ACTH and beta-endorphin: involvement of corticotropin-releasing hormone and vasopressin.
    Kjaer A; Knigge U; Bach FW; Warberg J
    Neuroendocrinology; 1992 Sep; 56(3):419-28. PubMed ID: 1331840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analogs of arginine vasopressin modified in position 3 with (R)-alpha-hydroxymethylphenylalanine.
    Lempicka E; Slaninova J; Olma A; Lammek B
    J Pept Res; 1999 May; 53(5):554-9. PubMed ID: 10424351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats.
    Juif PE; Poisbeau P
    Pain; 2013 Aug; 154(8):1449-56. PubMed ID: 23707282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of vasopressin receptors of rat urinary bladder and spleen.
    Thibonnier M; Snajdar RM; Rapp JP
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H115-20. PubMed ID: 3014903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists.
    Lammek B; Bankowski K; Misicka A; Manning M; Seto J; Sawyer WH
    J Med Chem; 1989 Jan; 32(1):244-7. PubMed ID: 2909737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
    Bankowski K; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arginine vasopressin and oxytocin increase intracellular calcium and cAMP in human glomerular epithelial cells in culture.
    Späth M; Pavenstädt H; Petersen J; Schollmeyer P
    Kidney Blood Press Res; 1996; 19(2):81-6. PubMed ID: 8871886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histamine- and stress-induced prolactin secretion: importance of vasopressin V1- and V2-receptors.
    Kjaer A; Knigge U; Warberg J
    Eur J Endocrinol; 1994 Oct; 131(4):391-7. PubMed ID: 7921229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin affects the oxytocin and prolactin responses to stress in male rats.
    Juszczak M
    J Physiol Pharmacol; 1998 Mar; 49(1):151-63. PubMed ID: 9594418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of V2 receptor activity on the pressor response to vasopressin in the rat.
    Shimizu K; Schwartz J; McGrath BP
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):349-52. PubMed ID: 1829666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.